Verastem, Inc. financial data

Symbol
VSTM on Nasdaq
Industry
Pharmaceutical Preparations
Location
117 Kendrick Street, Suite 500, Needham, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 499 % -15.2%
Debt-to-equity 155 % +64%
Return On Equity -194 % -58.6%
Return On Assets -64.5 % -11.7%
Operating Margin -1.76K % -3916%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40.2M shares +59.4%
Common Stock, Shares, Outstanding 26.9M shares +6.47%
Entity Public Float 187M USD
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 26.9M shares +51.5%
Weighted Average Number of Shares Outstanding, Diluted 201M shares +7.74%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 10M USD
Revenue from Contract with Customer, Excluding Assessed Tax 10M USD
Research and Development Expense 72.2M USD +53.9%
Costs and Expenses 109M USD +46.6%
Operating Income (Loss) -98.8M USD -33.1%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -89.5M USD -19.5%
Earnings Per Share, Basic -3.22 USD/shares +40.1%
Earnings Per Share, Diluted -0.31 USD/shares +77.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 83.4M USD -54.5%
Cash, Cash Equivalents, and Short-term Investments 83.4M USD -54.5%
Assets, Current 99.6M USD -47.5%
Property, Plant and Equipment, Net 46K USD +15%
Operating Lease, Right-of-Use Asset 816K USD -45.4%
Other Assets, Noncurrent 5M USD +24890%
Assets 106M USD -44.9%
Accounts Payable, Current 6.68M USD +46.7%
Employee-related Liabilities, Current 3.09M USD +17%
Accrued Liabilities, Current 17.2M USD +25%
Liabilities, Current 30.3M USD +46%
Operating Lease, Liability, Noncurrent 270K USD -78.4%
Other Liabilities, Noncurrent 51K USD
Liabilities 65.7M USD -4.74%
Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value 21.2M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -4K USD -167%
Retained Earnings (Accumulated Deficit) -867M USD -11.5%
Stockholders' Equity Attributable to Parent 18.9M USD -81.4%
Liabilities and Equity 106M USD -44.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.3M USD -39.5%
Net Cash Provided by (Used in) Financing Activities 846K USD -98.1%
Net Cash Provided by (Used in) Investing Activities 31M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 26.9M shares +6.47%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.52M USD -84.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 83.6M USD -54.6%
Deferred Tax Assets, Valuation Allowance 152M USD +13.8%
Deferred Tax Assets, Gross 153M USD +13.6%
Operating Lease, Liability 1.02M USD -46.2%
Depreciation 6K USD -80%
Payments to Acquire Property, Plant, and Equipment 21K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -89.5M USD -19.7%
Lessee, Operating Lease, Liability, to be Paid 1.09M USD
Property, Plant and Equipment, Gross 1.63M USD +0.43%
Operating Lease, Liability, Current 1.02M USD +18.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.08M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 546K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.15 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 70K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.08M USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 110M USD +6.69%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 546K USD 0%
Operating Lease, Payments 1.07M USD +2.19%
Preferred Stock, Shares Outstanding 1.2M shares +20%
Interest Expense 4.52M USD +35.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%